Alzheimer’s & Resveratrol Katharine Frost. Need 26 million people worldwide have Alzheimer’s. 1 in 10 people over 65 have Alzheimer’s 40% of people over.

Slides:



Advertisements
Similar presentations
Alzheimer’s Disease Edwin Onattu P. 3.
Advertisements

Etiopathogenesis of Alzheimer's disease
The Aging Brain The brain changes with age The frontal cortex & hippocampus are critical to learning, memory, planning and other cognitive activities,
Preventative and Therapeutic Treatment of Resveratrol on Alzheimer’s Disease using CL2006 and CL4176 C. elegan models Bradford Greaves.
Red Wine Benefits Through Resveratrol By Anthony Anastasio.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
ALZHEIMER'S DISEASE (AD)
Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006 Bradford Greaves.
Question: What do we know about the elusive nature of the pathogenesis of Alzheimer's disease? How can personalized medicine, or the application of genomics.
Preventative and Therapeutic treatment of resveratrol on Alzheimer’s Disease using CL2006 and CL4176 C. elegan models Bradford Greaves.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Alzheimer's disease By: Angelyn Johnson.
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
The Effects of Resveratrol and Melatonin on Drosophila melanogaster with Paraquat Induced Oxidative Stress By Anthony Anastasio.
Better Your Brain It's never too late to make smart lifestyle changes that will protect your health in years to come. Boost brainpower and keep your mind.
Alzheimer's disease Beta amyloid protein and the potential for anti-oxidants drugs.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Chronic psychosocial stress enhances long-term depression in a subthreshold amyloid-beta rat model of Alzheimer's disease Tran, Trinh, Srivareerat,et al.
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Alzheimer’s Disease Causes, Effects, and Treatments.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Alzheimer’s Disease. Alzheimer's is a the most common form of dementia. Nearly 50-80% of all dementia patients have Alzheimer's. It is a progressive fatal.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
Type in the name of the disease Created by:. Description Type in your description of the disease here.
What is Alzheimer’s Disease?. Neurons and Neurotransmitters Neurons are cells inside the brains. Chemical transmitters (neurotransmitters) which transport.
Alzheimer’s & the possible treatments effects of melatonin and resveratrol Katharine Frost.
Compound from Red Wine is Helpful to Slow the Development of Alzheimer Alzheimer is one of the most common diseases among the elderly as aging playing.
?v=pQO3Tq3KQL4 ohlTE.
Alzheimer’s Disease By: Nora Teen Health 8 Period 1.
National Institute on Aging
Alzheimer’s Disease Jeremy Toepp Period 6 Biology.
Epidemiology of Alzheimer’s Disease
Under the supervision of miklós jászberényi
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Alzheimer’s is a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time,
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Alzheimer’s Disease: Advances and Hope Trey Sunderland, M.D. Chief, Geriatric Psychiatry Branch National Institute of Mental Health Bethesda, Maryland.
Alzheimer’s Research UK is the UK’s leading charity specialising in finding preventions, treatments and a cure for dementia.
Alzheimer’s Disease By Evelyn B. Kelly 2-7 Healthy Brain Advanced Alzheimer ’ s.
Alzheimer's disease 蕭尚益 丁唯洋 蔡欣容. Outline introductionDisease mechanismPreventConclusion.
We Treat Alzheimers 20 years early? Can. Clinical neurologist-Reisa Sperling 1. Is a clinical neurologist, a neuroimaging researcher. 2.Is a leading force.
Alzheimer’s Disease Lizzy Butler & Efe Osemeha. Background Info Alzheimer’s Disease is a neurological disease that kill neurons causing the loss of memory.
Therapeutic Treatment of Resveratrol on Alzheimer’s Disease with CL2006 Bradford Greaves.
Alzheimer’s Disease (AD)
Norton-scientificcollection.com/collection. HEALTH NEWS Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer’s.
Alzheimer’s Disease What is Alzheimer’s Disease and what happens to the brain of someone affected by the disease?
Title: Alzheimer’s disease and the social
Alzheimer’s Disease Putting the pieces together
Red Wine Benefits Through Resveratrol
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial
Small section of the neocortex from a patient with Alzheimer disease showing two classical neuropathologic lesions of the disease. A. The modified silver.
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Q: How can we prevent or treat Alzheimer’s Disease?
Progress Report on Alzheimer’s Disease
Chapter 30 Delirium and Dementia
Diagnosing Patient #2 The two studs (you know who we are) (Zach and Jack in case you didn’t know)
A Control B AD C Control D AD Non immunodepletion Non immunodepletion
Q: How can we prevent or treat Alzheimer’s Disease?
Diagnosing Patient #2 The two studs (you know who we are) (Zach and Jack in case you didn’t know)
Advances in the War on Alzheimer's
Modifiers of Amyloid-beta Toxicity in Alzheimer’s Disease
Neuroplasticity Failure in Alzheimer's Disease
Presentation transcript:

Alzheimer’s & Resveratrol Katharine Frost

Need 26 million people worldwide have Alzheimer’s. 1 in 10 people over 65 have Alzheimer’s 40% of people over 80 have Alzheimer’s

Fundamentals Most common form of dementia (Segal and Wayne, 2009) Caused by accumulation of Ab peptide and neurofibrary tangles in brain (Segal and Wayne, 2009)

Model Organisms & Types of Alzheimer’s Drosophila make good model organism for studying Alzheimer’s (Korschun, 2006) 2 types of Alzheimer’s disease, hereditary and non hereditary (Korschun, 2006) APOE4 gene causes non hereditary Alzheimer’s (Korschun, 2006)

Non hereditary Alzheimer’s Non hereditary Alzheimer’s may be caused by oxidative stress (Korschun, 2006) Possible treatments for non hereditary Alzhiemer’s are high doses of anti oxidants (Cummings, 2009)

Resveratrol Found in grapes an red wine (Cummings, 2009) Studies show that it reduced & prevented the buildups of amyloid plaques (Patton, 2005) Possible treatment for Non hereditary Alzheimer’s; helps balance out oxidative stress (Patton, 2005)

Literature Review Philippe Marambaud (2008) found that Resveratrol as found in gapes, helps to prevent oxidative stress and therefore prevent the development and appearance of symptoms in non hereditary Alzheimer’s

Literature Review Srinivasan (2006) determined that melatonin may also have potential to be a treatment as it increases the survival of neurons under oxidative stress